A New Chapter for Edesa Biotech: A Fresh Financial Leader Emerges
Edesa Biotech appoints Peter J. Weiler as Chief Financial Officer, effective May 1, 2025, marking a significant leadership change. Weiler succeeds Stephen Lemieux, who transitions to an advisory role, maintaining…
Why Edesa Biotech’s Latest Leadership Move Could Be a Game Changer
Edesa Biotech undergoes a pivotal leadership change as Peter J. Weiler replaces Stephen Lemieux. Weiler brings extensive experience from leadership roles at Exzell Pharma, Biosyent Inc., and Cipher Pharmaceuticals. His…
The Strategic Shift at Edesa Biotech: A New CFO Heralds a New Era
Peter J. Weiler is appointed CFO of Edesa Biotech starting May 1, 2025, marking a strategic leadership transition. Weiler brings extensive experience from roles in biotech and pharmaceuticals, previously as…
The Surprising Financial Maestro Set to Propel Edesa Biotech into a New Era
Edesa Biotech appoints Peter J. Weiler as Chief Financial Officer, signaling strategic financial enhancement amidst leadership transitions. Weiler's extensive experience in biotech and pharmaceuticals, highlighted by his role at Exzell…
The Surprising Leadership Change at Edesa Biotech: What It Means for the Future
Edesa Biotech appoints Peter J. Weiler as CFO starting May 1, 2025, succeeding Stephen Lemieux. Weiler brings extensive experience from leadership roles at Exzell Pharma and Biosyent Inc., blending scientific…
Meet the New Financial Maverick Guiding Edesa’s Future
Edesa Biotech announces Peter J. Weiler as the new CFO, effective May 1, 2025, signaling a pivotal shift in financial strategy. Weiler's extensive experience in the biotech and pharma sectors,…
How One Biotech Company’s New CFO Appointment Could Change Its Future—And Why You Should Pay Attention
Peter J. Weiler takes over as CFO of Edesa Biotech, starting May 1, 2025, bringing extensive biotech industry experience. The transition aims to enhance Edesa's financial strategies and align them…
Meet the Visionary Steering Edesa Biotech’s Future: A Transformative Leadership Change
Peter J. Weiler joins Edesa Biotech as Chief Financial Officer in May, marking a pivotal transition for the company and the broader biotech industry. Weiler brings extensive experience from Exzell…
The New Financial Architect: Transforming the Future of Edesa Biotech
Edesa Biotech appoints Peter J. Weiler as the new Chief Financial Officer, effective May 1, 2025, succeeding Stephen Lemieux. Weiler's extensive background spans key roles at Exzell Pharma, Biosyent Inc.,…
A New Era at Edesa Biotech: The Bold Leadership Shift Shaping Its Future
Peter J. Weiler appointed as new CFO of Edesa Biotech, starting May 1, 2025. Weiler brings extensive experience, with previous roles at Exzell Pharma and Biosyent Inc. Weiler holds an…